Selumetinib - AstraZeneca
At a glance
- Drug Originator Array BioPharma
- Drug Licenced by AstraZeneca
- Drug Class Amides; Amines; Antineoplastics; Benzimidazoles; Halogenated hydrocarbons; Small molecules
- Mechanism of Action MAP kinase kinase 1 inhibitors; MAP kinase kinase 2 inhibitors
- USA Patent Applicants ASTRAZENECA
- USA Patents 12
- NDAs 1
- International Patents 198
- Patent Applications 2,416
Table of Contents

Disclaimer